This expert-led webinar presented by Heather Cheng, MD, PhD, discusses the importance of identifying hereditary cancer risk mutations for prostate cancer. Dr. Cheng speaks about prostate cancer treatment and trials, as well as, screening trials for men with hereditary prostate cancer. Dr. Cheng is a medical oncologist with the University of Washington. She designs and conducts therapeutic clinical trials, particularly for men whose cancers have mutations in genes related to DNA repair, such as BRCA2 and BRCA1.